SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.78%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$318M
AUM Growth
+$318M
(-44%)
Cap. Flow
-$316M
Cap. Flow
% of AUM
-99.43%
Top 10 Holdings %
Top 10 Hldgs %
49.1%
Holding
82
New
14
Increased
12
Reduced
20
Closed
21
Top Buys
| 1 |
Astria Therapeutics
ATXS
|
$6.99M |
| 2 |
FIVE9
FIVN
|
$6.45M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$5.81M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$5.05M |
| 5 |
Generac Holdings
GNRC
|
$5.03M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$43.1M |
| 2 |
AstraZeneca
AZN
|
$33.7M |
| 3 |
Sanofi
SNY
|
$31.7M |
| 4 |
Novo Nordisk
NVO
|
$30.4M |
| 5 |
Merck
MRK
|
$27.3M |
Sector Composition
| 1 | Healthcare | 88.5% |
| 2 | Technology | 3.25% |
| 3 | Industrials | 2.93% |
| 4 | Communication Services | 0.13% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merus
MRUS
$4.98B
| $4.9M | 1.05% | 316,993 +3,667 | +1% | +$56.7K |
|
27
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $4.6M | 0.99% | +307,283 | New | +$4.6M |
|
28
Leonardo DRS
DRS
$11.1B
| $4.29M | 0.92% | +335,557 | New | +$4.29M |
|
|
ISEE
29
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.19M | 0.9% | 195,591 -386,238 | -66% | -$8.27M |
|
|
BLU
30
DELISTED
BELLUS Health Inc.
BLU
| $4.03M | 0.86% | 489,860 +25,000 | +5% | +$206K |
|
31
Rigel Pharmaceuticals
RIGL
$697M
| $3.42M | 0.73% | 2,278,845 +116,259 | +5% | +$174K |
|
|
KDNY
32
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.33M | 0.72% | 127,200 -407,158 | -76% | -$10.7M |
|
33
Camtek
CAMT
$3.78B
| $2.42M | 0.52% | +110,000 | New | +$2.42M |
|
34
Rezolute
RZLT
$619M
| $2.39M | 0.51% | 1,155,897 | – | – |
|
35
89bio
ETNB
$1.34B
| $2.3M | 0.49% | 180,600 -478,184 | -73% | -$6.09M |
|
36
Biogen
BIIB
$19.4B
| $2.08M | 0.45% | 7,516 -47,984 | -86% | -$13.3M |
|
37
Stoke Therapeutics
STOK
$1.08B
| $1.74M | 0.37% | 188,640 +31,440 | +20% | +$290K |
|
|
INZY
38
DELISTED
Inozyme Pharma
INZY
| $1.71M | 0.37% | 1,625,058 +450,000 | +38% | +$473K |
|
39
PMV Pharmaceuticals
PMVP
$74.2M
| $1.63M | 0.35% | 187,800 | – | – |
|
40
BioAtla
BCAB
$26.7M
| $1.54M | 0.33% | +186,600 | New | +$1.54M |
|
|
ALPN
41
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.47M | 0.32% | 200,000 | – | – |
|
42
Werewolf Therapeutics
HOWL
$59.9M
| $1.28M | 0.28% | 626,810 | – | – |
|
43
MediWound
MDWD
$182M
| $1.02M | 0.22% | 75,413 -613,303 | -89% | -$8.27M |
|
|
AUTL
44
Autolus Therapeutics
AUTL
$399M
| $950K | 0.2% | +500,000 | New | +$950K |
|
45
Applied Materials
AMAT
$128B
| $828K | 0.18% | +8,499 | New | +$828K |
|
|
INFI
46
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $819K | 0.18% | 1,476,000 | – | – |
|
47
Taboola.com
TBLA
$991M
| $370K | 0.08% | +120,000 | New | +$370K |
|
|
MGIC
48
Magic Software Enterprises
MGIC
$997M
| $352K | 0.08% | 21,981 -59,312 | -73% | -$950K |
|
|
IMTXW
49
DELISTED
Immatics N.V. Warrants
IMTXW
| $251K | 0.05% | 100,000 | – | – |
|
50
Spyre Therapeutics
SYRE
$996M
| $198K | 0.04% | +440,837 | New | +$198K |
|